Introduction
South African whites have the highest death rate from coronary heart disease in the Western world.' The reasons for this are not clear but one factor may be their high prevalence of familial hypercholesterolaemia (or type II hyperlipoproteinaemia of Fredrickson) . This is perhaps most strikingly illustrated by the fact that in a short time in a single clinic we have seen 34 patients with the homozygous form of familial hypercholesterolaemia. We describe here the epidemiological, genetic, clinical, and biochemical features of these patients and discuss the reasons for, and some implications of, the remarkable frequency of familial hypercholesterolaemia in South Africa.
Patients and methods
Thirty-four patients with homozygous familial hypercholesterolaemia from 27 families were seen at the lipid disorders clinic of the Johannesburg Hospital from 1972 to 1979. Twenty families produced one homozygote each and in each of the remaining seven families there were two homozygous siblings. Pedigrees and national origins were studied both in the clinic and by home visits by a trained genetics field worker. During the same period the clinic also registered 351 heterozygotes with familial hypercholesterolaemia belonging to 154 families.
The prevalence of homozygous familial hypercholesterolaemia was estimated in the population at risk and used in the Hardy-Weinberg equation to 
Results

GENETIC FEATURES AND DIAGNOSIS OF THE HOMOZYGOUS STATE
Family studies invariably showed an autosomal monogenic dominant pattern of inheritance. Figure 1 shows were Afrikaans, 10% British, and 10% diverse but mainly Ashkenazi Jews.
All the patients lived within about 150 km of Johannesburg, most of them in the southern half of Transvaal Province (fig 2) . The total white population of this area in 1979 was 1 942 000, of whom 1 146 000 were Afrikaners. Of the Afrikaners 951 000 were under the age of 50 years; and in 1979 28 homozygotes aged 3 to 46 years were alive. The prevalence of homozygotes in this Afrikaner population at risk was therefore 0-00003 or about 1 in 30 000. This figure is conservative since we did not systematically ascertain all the living homozygotes in this Afrikaner population, and we are aware of several other patients diagnosed elsewhere in the area.
Knowing the approximate prevalence of homozygotes in the Afrikaner population at risk, we estimated the prevalence of heterozygotes from the Hardy-Weinberg equation.2 If the frequency of the allele for familial hypercholesterolaemia is q, its frequency is given as BRITISH MEDICAL JOURNAL VOLUME 281 6 SEPTEMBER 1980 the square root ofthe frequency of the homozygotes-that is, y000003
= 0-0055. The frequency of the normal allele, p, is 1-q = 0-9945. The heterozygote or carrier frequency is given by 2pq, which is about 1 in 100.
CLINICAL CHARACTERISTICS OF THE HOMOZYGOTES
The number of males and females was the same. Their ages in 1979 or at death ranged from 3 to 46 years (see table) . Six patients had survived for 30 years or more. Body weights were mostly normal.
Every patient had planar or tendon xanthomas, which had appeared during the first decade of life in all cases. All but the youngest patient had orange or yellow planar xanthomas in the skin over the limbs or buttocks, which, according to Fredrickson, 5 The blood lipid concentrations for each patient shown in the table were the means of at least three determinations. Serum total cholesterol values varied from 14 7 to 28 0 mmol/l (565 and 1077 mg/100 ml) and were unrelated to age or sex. Most of the cholesterol was carried in the LDL form. By contrast, HDL cholesterol concentrations were distinctly low, being on average about half the values of normal subjects of comparable age.5 The HDL:LDL cholesterol ratios were therefore very low indeed, ranging from 0-02 to 0 06. The ratios varied little, with 21 of the 34 patients having values of 0 02 or 0-03, and did not correlate with the clinical prevalence of coronary heart disease. Normally the ratio varies from 0-2 to 1 0 or more in the earlier decades of life.
Most patients had normal serum triglyceride concentrations, and none were diabetic or hyperuricaemic.
second half of the seventeenth century. In this bountiful land the founders, who were also fertile and healthy, multiplied rapidly. During the eighteenth century, for example, their numbers increased from about 1200 to 15 000.11 If one or two of these original founders had happened to possess the familial hypercholesterolaemia allele it could explain the present high frequency of the gene. Dean hypercholesterolaemia. Goldstein and Brown's concept of familial hypercholesterolaemia as a group of disorders characterised by deficiencies or abnormalities of LDL receptors does not provide an obvious explanation.13 Also if the entire arterial tree and all tissues in all the homozygotes are exposed from an early age to the extremely unfavourable combination of very high concentrations of atherogenic LDL and distinctly low concentrations of anti-atherogenic HDL, how do we explain the variable natural history, the dissociation in severity between the arterial and cutaneous lesions, and the striking predominance of coronary artery disease clinically ? Possible explanations include genetic heterogeneity, interactions with other risk factors for arterial disease, and, perhaps most important, the reactivity of the tissues.
